The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.40
Bid: 133.80
Ask: 134.60
Change: 6.60 (5.16%)
Spread: 0.80 (0.598%)
Open: 129.60
High: 137.20
Low: 129.00
Prev. Close: 127.80
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Jul 2015 16:32

RNS Number : 3508U
NCC Group PLC
28 July 2015
 

28 July 2015

 

NCC Group plc ("Company")

 

Grant of new Share Options

 

Today the Directors/Persons Discharging Managerial Responsibilities ("PDMRs") listed below were granted share options over a total of 525,219 ordinary shares of 1 pence each ("Ordinary Shares") pursuant to the Company's Long Term Incentive Plan ("LTIP"). The new options granted pursuant to the Company's LTIP will become exercisable in the period from 1 June 2018 to 27 July 2019. The exercise price is £1.00 on each occasion of exercise.

 

Those Directors/PDMRs listed below were also today granted share options over a total of 94,382 Ordinary Shares pursuant to the Company's Deferred Annual Bonus Plan ("DB Plan"). The new options granted pursuant to the DB Plan will become exercisable in the period from 1 June 2017 to 27 July 2025. The exercise price is £1.00 on each occasion of exercise.

 

 

Name

Director/ PDMR

Number of options awarded pursuant to the LTIP over Ordinary Shares

Number of options awarded pursuant to the DB Plan over Ordinary Shares

Total number of shares over which options held as at the date of this announcement

Robert Cotton

Director

218,421

52,614

826,072

Atul Patel

Director

101,754

23,396

384,050

Roger Rawlinson

PDMR

109,649

18,372

419,751

Daniel Liptrott

PDMR

95,395

-

204,467

The above transaction has been notified for the purposes of DTR 3.1.2R and DTR 3.1.4R.

Total voting rights

The total Ordinary Shares in issue is 229,316,313 (which includes 116,714 treasury shares). The number of voting rights in issue is 229,199,599 and should be used by shareholders as the denominator in the calculation of their interest in the Company.

 

Enquiries:

NCC Group (www.nccgroup.com)

Helen Nisbet, Company Secretary

Peel Hunt

0161 209 5251

Dan Webster/Richard Brown

020 7418 8861

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASXPADFSEFF
Date   Source Headline
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review
20th Jul 20234:51 pmRNSHolding(s) in Company
19th Jul 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.